Skip to the main content.

3 min read

KBI Biopharma and Selexis Hold Joint Ribbon Cutting of the Expanded State-of-the-Art Facility in Geneva, Switzerland

Jul 6, 2022 7:45:00 AM
News
Read More

2 min read

KBI Biopharma SA and Selexis SA Expand in Europe by Opening an Integrated Biologics Manufacturing Facility in Geneva, Switzerland

Jun 14, 2022 7:45:00 AM
News
Read More

3 min read

JSR Appoints Veteran Biotech and CDMO Leader Mark W. Womack to Lead KBI Biopharma and Selexis SA

May 2, 2022 7:00:00 AM
News
Read More

2 min read

KBI Biopharma Holds Ribbon Cutting for New Commercial Manufacturing Facility

Apr 21, 2022 7:30:00 AM
News
Read More

3 min read

Oragenics Engages KBI Biopharma to Support Development of the Intranasal COVID-19 Vaccine Candidate NT-CoV2-1

Mar 10, 2022 8:00:00 AM
News
Read More

3 min read

KBI Biopharma Completes Eurofins DiscoverX Products Specialized Bioassay Certification Program

Oct 11, 2021 7:50:00 AM
News
Read More

1 min read

4 November 2021 11:00 am ET | Quantitation of Particle Profiles in Biologics and Cell Therapeutics.

Jul 2, 2021 1:20:05 PM
Webinars
Read More

3 min read

Adalta Secures AD-214 Resupply Under KBI Biopharma MSA

Jul 2, 2021 11:04:50 AM
News
Read More

2 min read

Selexis and KBI Biopharma Enter into Agreements with Immatics for Integrated Approach to Advance Immatics TCR Bispecific Program Towards IND

Jun 29, 2021 9:47:48 AM
News
Read More

2 min read

KBI Biopharma Enters Commercial Manufacturing Agreement with AM-Pharma to Prepare for the Commercial Launch of Lead Program in Acute Kidney Disease

Jun 17, 2021 1:15:22 PM
News
Read More
1 2 3 4 5 Next